Imac holdings introduces ignite proteomics: a new standard for matching patients with the right cancer therapies

Nashville, tn, jan. 27, 2025 (globe newswire) -- imac holdings, inc. (nasdaq: back) (“imac holdings” or the “company”) has launched ignite proteomics llc (“ignite”), its new subsidiary dedicated to helping doctors select the most effective cancer treatments based on protein-level insights. this move addresses a growing need for better, faster ways to personalize therapy in breast cancer and beyond.
BACK Ratings Summary
BACK Quant Ranking